Barings’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-2,590
| Closed | -$207K | – | 684 |
|
2019
Q3 | $207K | Hold |
2,590
| – | – | ﹤0.01% | 626 |
|
2019
Q2 | $202K | Sell |
2,590
-4,450
| -63% | -$347K | ﹤0.01% | 653 |
|
2019
Q1 | $826K | Hold |
7,040
| – | – | 0.02% | 433 |
|
2018
Q4 | $767K | Buy |
7,040
+2,450
| +53% | +$267K | 0.01% | 429 |
|
2018
Q3 | $587K | Hold |
4,590
| – | – | 0.01% | 590 |
|
2018
Q2 | $519K | Buy |
4,590
+2,140
| +87% | +$242K | 0.01% | 635 |
|
2018
Q1 | $275K | Hold |
2,450
| – | – | ﹤0.01% | 829 |
|
2017
Q4 | $362K | Sell |
2,450
-1,700
| -41% | -$251K | ﹤0.01% | 790 |
|
2017
Q3 | $486K | Hold |
4,150
| – | – | 0.01% | 651 |
|
2017
Q2 | $538K | Sell |
4,150
-15,190
| -79% | -$1.97M | 0.02% | 606 |
|
2017
Q1 | $2.62M | Buy |
19,340
+9,670
| +100% | +$1.31M | 0.03% | 515 |
|
2016
Q4 | $1.39M | Hold |
9,670
| – | – | 0.03% | 369 |
|
2016
Q3 | $1.14M | Sell |
9,670
-7,400
| -43% | -$874K | 0.03% | 405 |
|
2016
Q2 | $1.81M | Buy |
17,070
+3,300
| +24% | +$350K | 0.05% | 327 |
|
2016
Q1 | $1.53M | Hold |
13,770
| – | – | 0.04% | 366 |
|
2015
Q4 | $2.16M | Buy |
13,770
+10,640
| +340% | +$1.67M | 0.05% | 267 |
|
2015
Q3 | $411K | Sell |
3,130
-5,140
| -62% | -$675K | 0.01% | 678 |
|
2015
Q2 | $1.44M | Buy |
8,270
+2,360
| +40% | +$411K | 0.04% | 399 |
|
2015
Q1 | $1.02M | Hold |
5,910
| – | – | 0.02% | 498 |
|
2014
Q4 | $765K | Hold |
5,910
| – | – | 0.02% | 539 |
|
2014
Q3 | $760K | Sell |
5,910
-17,180
| -74% | -$2.21M | 0.02% | 543 |
|
2014
Q2 | $2.04M | Buy |
23,090
+11,100
| +93% | +$982K | 0.06% | 309 |
|
2014
Q1 | $1.13M | Buy |
11,990
+690
| +6% | +$64.9K | 0.04% | 425 |
|
2013
Q4 | $1.28M | Buy |
11,300
+1,400
| +14% | +$158K | 0.05% | 362 |
|
2013
Q3 | $781K | Sell |
9,900
-5,900
| -37% | -$465K | 0.03% | 489 |
|
2013
Q2 | $1.04M | Buy |
+15,800
| New | +$1.04M | 0.05% | 396 |
|